All Viruses articles – Page 7
-
NewsDengue vaccine shows favorable safety profile in travellers from non-endemic regions
A prospective study of more than 1,000 people vaccinated with TAK-003 in Catalonia found no serious adverse events and provides new evidence on the vaccine’s short-term safety in travelers.
-
NewsGladstone launches Center for PhAIge Therapy to harness AI in the fight against drug-resistant infections
Gladstone Institutes has received funding to establish the Center for PhAIge Therapy, a research center that will develop new phage-based treatments for antibiotic-resistant bacterial infections. The five-year grant makes Gladstone one of three institutions across the country selected to lead this coordinated effort.
-
NewsT cells may be key to stopping measles virus—and its deadly relatives
Scientists have discovered how T cells target paramyxoviruses, a viral family that includes measles virus and Nipah virus. Instead of vaccinating against one virus at a time, the researchers found that activating “cross-reactive” T cells may protect against the wider paramyxovirus family.
-
NewsScientists recreate enterovirus infection in a new model of the human intestine
A miniaturized, biomimetic model of the human intestine successfully reproduced long-term enterovirus A71 (EV-A71) infection, report researchers. Using this innovative platform, they shed light on how this virus grows in the intestine without triggering a strong immune response.
-
News‘Accidental’ discovery lays foundation for novel flu treatment strategies
Scientists investigating how influenza viruses replicate within cells “accidentally” discovered that different flu viruses use distinct strategies to infiltrate cells in the first place. They also found that it is possible to target specific molecules to prevent the viruses from entering new cells, thereby stopping their replication.
-
NewsWhat is the link between HIV and chronic pain?
A mouse study reveals a mechanism linking HIV to chronic pain. Targeting each of the molecular players in this mechanism alleviates pain and may hold treatment promise for HIV-associated pain, though more work is needed.
-
NewsPrecigen presents new long-term durability data for PAPZIMEOS, recently granted seven-year market exclusivity
Precigen, Inc. has announced updated long-term follow-up data from the pivotal study of PAPZIMEOS™ (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP).
-
NewsNew analysis confirms benefits of childhood flu vaccines
Pediatric flu vaccines significantly reduce the number of childhood cases of influenza, new research confirms. The findings show that for every 100 children vaccinated, between nine and 14 fewer children catch the flu.
-
CareersA week in the life of a Parvovirus researcher
Alejandro Fernández Llorente works as a predoctoral researcher at Centro de Biología Molecular Severo Ochoa (CBM-CSIC), a prestigious biomedical research centre located in Madrid, Spain.
-
NewsProtection for newborns: New treatment aims to prevent meningitis without antibiotics
One of the leading pathogens responsible for meningitis cases in newborn babies is the K1 form of the E. coli bacterium. Now, researchers have developed a triple-pronged approach that seeks to prevent transmission to newborns.
-
NewsResearchers discover tick protein that may block disease transmission
Researchers have found that ticks produce an exosomal glycine-rich protein that plays a vital role in helping ticks feed and transmit viruses. When they used genetic tools to silence the gene responsible for this protein, ticks lacking the protein struggled to feed effectively and showed reduced body weight after feeding.
-
NewsExperts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus
In response to the current outbreak of Ebola disease caused by Bundibugyo virus, WHO convened several of its expert and advisory groups to assess potential vaccines and therapeutics for both prevention and treatment of Bundibugyo virus disease (BVD).
-
NewsExperimental HIV vaccine achieves a long-sought goal
In a first for the field, all non-human primates given a new series of vaccines generated antibodies capable of fighting multiple strains of HIV. It brings researchers closer to a vaccine effective against the vast diversity of HIV strains circulating worldwide.
-
NewsArchaic DNA may lower defences against common DNA viruses in people today
Researchers explored the contribution of archaic DNA - primarily Neandertal ancestry - to the DNA viral load of participants in the UK Biobank. By analysing viral sequences detected in large-scale genomic data, they asked whether archaic variants correlate with the presence or quantity of common DNA viruses.
-
NewsResearchers may now understand why chikungunya virus infections turn chronic
About half of people infected with chikungunya virus will progress to a chronic form of the disease. A new study finds that chikungunya virus persists in joint-associated macrophages, a specialized type of white blood cell that helps the body defend against pathogens.
-
NewsMaternal infection: A critical driver of offspring cardiac dysfunction
A new study reveals that maternal infection causes severe metabolic disturbances within the offspring’s heart, most notably enriching differentially expressed genes in lipid, energy, and amino acid metabolism. The infection also heavily suppressed cardiac cell proliferation.
-
NewsCommon illnesses, not hantavirus, pose greatest cruise and travel risk
Travelers booked on cruises this summer, or considering booking, shouldn’t change their plans out of fear of hantavirus, one researcher says. They should be aware of more common viral illnesses that occur in cruise settings such as norovirus, seasonal respiratory viruses, COVID-19 and influenza.
-
NewsHeart health may have impacted the risk of severe COVID-19 infection during the pandemic
Adults with highest heart health scores at the beginning of the pandemic were nearly half as likely to be hospitalized or die from COVID-19 when compared to those with the lowest scores, according to new research.
-
FeaturesEquity and the response to Covid 19 - Preparing for the next pandemic in Aotearoa New Zealand
Aotearoa New Zealand enacted an effective response to the Covid-19 pandemic. The government approach to the first few cases in March 2020 was to implement a swift ‘go hard and go early’ response. Borders were closed to non-residents, lockdowns were enforced, and infection was effectively eliminated within 76 days of ...
-
NewsScientists identify nearly two dozen antiviral compounds that could treat Ebola virus
Recent advances in artificial intelligence have enabled scientists to identify nearly two dozen antiviral compounds that could potentially treat a rare species of Ebola virus (Bundibugyo virus) currently affecting the Democratic Republic of Congo.